IP Library › Granted Patent US 11,325,957
Granted Patent B2
US 11,325,957 · App. 16/010,805 · Granted May 10, 2022

Methods and compositions for reducing the immunogenicity of chimeric notch receptors

Inventors: Amy Gilbert (San Francisco, CA); Vladimir Slepushkin (Vallejo, CA); Peter Emtage (Lafayette, CA); Anselm Levskaya (Oakland, CA); Spencer Scott (San Francisco, CA)
Assignee: Cell Design Labs, Inc.
C07K14/4702A61K48/00C07K14/4705C07K14/705C07K14/70517C07K14/71C07K16/28C07K16/2803C07K19/00C12N5/10C12N15/63C12N15/85A61K2039/5156A61P35/04C07K16/462C07K2317/569C07K2317/622C07K2317/626C07K2317/70C07K2319/00C07K2319/02C07K2319/03C07K2319/09C07K2319/33C07K2319/41C07K2319/50C07K2319/70C07K2319/71C07K2319/80C07K2319/95C12N2740/16043C12N2830/15C12N2830/85
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,325,957
App. No.
16/010,805
Granted
May 10, 2022
Kind
B2
Abstract

The present invention relates to methods and compositions for reducing the immunogenicity of chimeric Notch receptors, and specifically to transcription factors useful for controlling gene expression delivered to tissues by such chimeric Notch receptors.

Claims (18)

1. A nucleic acid comprising a nucleotide sequence encoding a chimeric Notch polypeptide comprising, from N-terminal to C-terminal and in covalent linkage: a) an extracellular domain comprising a binding agent that specifically binds to an antigen; b) a Notch 2 or Notch 3 core region; c) one or more proteolytic cleavage sites; and d) an intracellular domain comprising a transcriptional regulator, wherein binding of the binding agent to the antigen induces cleavage of the Notch polypeptide at the one or more proteolytic cleavage sites, thereby releasing the intracellular domain and the transcriptional regulator;

wherein the transcriptional regulator comprises a DNA binding domain of human origin and a transactivation domain of human origin;

wherein the transactivation domain is selected from the group consisting of RelA (p65), YAP, WWTR1 (TAZ), and CREB3 (LZIP); and

wherein the Notch 2 or Notch 3 core region comprises a human Lin12 LNR.

2. A nucleic acid as described in claim 1 , wherein said binding agent comprises an antibody.

3. A nucleic acid as described in claim 2 , wherein said antibody is selected from the group consisting of scFv, bispecific antibody, nanobody, or bite.

4. A nucleic acid as described in claim 3 , wherein said transcriptional regulator is a transcriptional activator.

5. A recombinant vector comprising the nucleic acid of claim 4 .

6. A nucleic acid as described in claim 1 , wherein said transcriptional regulator is from the Hepatocyte Nuclear Factor (HNF) transcriptional regulator family.

7. A nucleic acid as described in claim 6 , wherein said transcriptional regulator is HNF1 alpha or HNF1 beta.

8. A recombinant vector comprising the nucleic acid of claim 6 .

9. A recombinant vector comprising the nucleic acid of claim 1 .

10. A host cell transformed with the nucleic acid of claim 1 .

11. The host cell of claim 10 , wherein the cell is a macrophage.

12. The host cell of claim 11 , wherein the macrophage is derived from monocytes.

13. A method of making a chimeric Notch polypeptide comprising a transcriptional regulator wherein said transcriptional regulator comprises a DNA binding domain of human origin, and wherein said method comprises culturing a host cell of claim 10 .

14. A nucleic acid as described in claim 1 , wherein the Notch 2 or Notch 3 core region further comprises a Nuclear Localization Signal (NLS).

15. A recombinant vector comprising the nucleic acid of claim 14 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2018
From: GILBERT, AMY; SLEPUSHKIN, VLADIMIR; EMTAGE, PETER; LEVSKAYA, ANSELM; SCOTT, SPENCER
To: CELL DESIGN LABS, INC.
Reel/Frame 046211/0615 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2018
From: GILBERT, AMY; SLEPUSHKIN, VLADIMIR; EMTAGE, PETER; LEVSKAYA, ANSELM; SCOTT, SPENCER
To: CELL DESIGN LABS, INC.
Reel/Frame 046164/0772 →
Continuity (3)
Provisional Application 62603993 · Jun 19, 2017
Provisional Application 62556765 · Sep 11, 2017
Related Publication 20180362603A1 · Dec 20, 2018
Cited By (4)
US 12,226,435 US 12,233,090 US 12,617,825 US 12,662,675